FdaApplication
NDA 020639
Identifiers
- fda_app_no: NDA020639
Properties
| Property | Value |
|---|---|
| applicant_name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| application_type | NDA |
| approval_date | 1997-09-26 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEROQUEL | QUETIAPINE FUMARATE | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SEROQUEL | QUETIAPINE FUMARATE | EQ 100MG BASE | TABLET;ORAL |
| SEROQUEL | QUETIAPINE FUMARATE | EQ 400MG BASE | TABLET;ORAL |
| SEROQUEL | QUETIAPINE FUMARATE | EQ 300MG BASE | TABLET;ORAL |
| SEROQUEL | QUETIAPINE FUMARATE | EQ 200MG BASE | TABLET;ORAL |
| SEROQUEL | QUETIAPINE FUMARATE | EQ 50MG BASE | TABLET;ORAL |
| SEROQUEL | QUETIAPINE FUMARATE | EQ 25MG BASE | TABLET;ORAL |
7 products